Evidence map›Paper›PMID 31752314›Full record

ArticleMicromachines2019

Tetrafluoroethylene-Propylene Elastomer for Fabrication of Microfluidic Organs-on-Chips Resistant to Drug Absorption.

Emi Sano, Chihiro Mori, Naoki Matsuoka, Yuka Ozaki, Keisuke Yagi, Aya Wada, Koichi Tashima, Shinsuke Yamasaki, Kana Tanabe, Kayo Yano and 1 more

Abstract read
In one paragraph

Article in Micromachines, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Engineering in vitro vascular microsystems.Microsystems & nanoengineering · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Emerging technologies and their impact on regulatory science.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  9. Article
  10. Human microphysiological models of airway and alveolar epithelia.American journal of physiology. Lung cellular and molecular physiology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Microphysiological systems: What it takes for community adoption.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Biomedical Application of Functional Materials in Organ-on-a-Chip.Frontiers in bioengineering and biotechnology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emi SanoDepartment of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan.
Chihiro MoriDepartment of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan.
Naoki MatsuokaAGC Inc, Tokyo 100-8405, Japan.ORCID 0000-0003-3136-9997
Yuka OzakiDepartment of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan.
Keisuke YagiAGC Inc, Tokyo 100-8405, Japan.
Aya WadaAGC Inc, Tokyo 100-8405, Japan.
Koichi TashimaAGC Inc, Tokyo 100-8405, Japan.
Shinsuke YamasakiAGC Inc, Tokyo 100-8405, Japan.
Kana TanabeAGC Inc, Tokyo 100-8405, Japan.
Kayo YanoDepartment of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan.
Yu-Suke TorisawaDepartment of Micro Engineering, Kyoto University, Kyoto 615-8540, Japan.

Funding

Japan Agency for Medical Research and Development JP18gm5810008Japan Society for the Promotion of Science JP17H02082
6 · The paper itself

Abstract

Organs-on-chips are microfluidic devices typically fabricated from polydimethylsiloxane (PDMS). Since PDMS has many attractive properties including high optical clarity and compliance, PDMS is very useful for cell culture applications; however, PDMS possesses a significant drawback in that small hydrophobic molecules are strongly absorbed. This drawback hinders widespread use of PDMS-based devices for drug discovery and development. Here, we describe a microfluidic cell culture system made of a tetrafluoroethylene-propylene (FEPM) elastomer. We demonstrated that FEPM does not absorb small hydrophobic compounds including rhodamine B and three types of drugs, nifedipine, coumarin, and Bay K8644, whereas PDMS absorbs them strongly. The device consists of two FEPM layers of microchannels separated by a thin collagen vitrigel membrane. Since FEPM is flexible and biocompatible, this microfluidic device can be used to culture cells while applying mechanical strain. When human umbilical vein endothelial cells (HUVECs) were subjected to cyclic strain (~10%) for 4 h in this device, HUVECs reoriented and aligned perpendicularly in response to the cyclic stretch. Moreover, we demonstrated that this device can be used to replicate the epithelial-endothelial interface as well as to provide physiological mechanical strain and fluid flow. This method offers a robust platform to produce organs-on-chips for drug discovery and development.

Indexed as

drug absorptionfluoroelastomermicrofluidicsorgans-on-chips

Identifiers

PMID31752314
PMCPMC6915658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.